Check out Debra Wujcik's takeaways from her presentation at #AMCCBSVirtual. She talked about the benefits and crucial data that can be harnessed when using Remote Symptom Monitoring and ePRO platforms.

1. #AMCCBS Virtual
Conference Takeaways
Remote Symptom Monitoring Drives the Carevive
OPT-IN® Research Program
3
20
21 2021 Carevive Systems, Inc. All rights reserved.
Confidential & Proprietary information. Do not distribute.

2. Key Takeaway 1
USING REMOTE SYMPTOM MONITORING PLATFORMS (RSM) CAN BE
USED TO HARNESS DISEASE-SPECIFIC, REAL-WORLD PATIENT
EXPERIENCE DATA
2021 Carevive Systems, Inc. All rights reserved.
Confidential & Proprietary information. Do not distribute.
• Carevive PROmpt® a remote symptom monitoring platform is a tool for
both patient and providers
• Patients can:​
- Report their symptoms on any device—phone, tablet, or computer​
- Review their care management plan at any time​
- Receive real-time, self-management advice for non-emergencies​
- Real-time communication for severe symptoms​
• Providers can:
- Get real-time electronic health record (EHR) alerting of severe
symptoms​
- View symptom trending dashboards​
- Receive EHR documentation​

3. Key Takeaway 2
OPT-IN® IS CONSORTIUM OF CLINICIAN INVESTIGATORS USING
PROmpt® AS PART OF ROUTINE CARE
2021 Carevive Systems, Inc. All rights reserved.
Confidential & Proprietary information. Do not distribute.
• Launched in May 2020
• Currently includes 5 disease registries (breast, lung, ovarian cancer,
multiple myeloma, and acute myelogenous leukemia) with 9 more
disease registries planned
• ​Cancer centers that participate in OPT-IN® are Carevive research
partners and investigators for studies being conducted on the real-world
patient with cancer experience

4. Key Takeaway 3
REAL WORLD EVIDENCE STUDIES UNLOCK CRITICAL PATIENT
DATASETS
2021 Carevive Systems, Inc. All rights reserved.
Confidential & Proprietary information. Do not distribute.
• Cancer Centers can:
- Improve patient outcomes​
- Engage in pragmatic research​
- Benchmark to the OPT-IN network​
- Receive revenue for RWE study participation​
- Receive quarterly reports
• Life Sciences can:
- Access real world data for drug development, commercial, and
market​
- Bespoke research

5. Key Takeaway 4
ANALYSIS OF SYMPTOM ALERTS CAN REVEAL AT-RISK
POPULATIONS AND OTHER KEY INSIGHTS
2021 Carevive Systems, Inc. All rights reserved.
Confidential & Proprietary information. Do not distribute.
• Monitor patient experience and volume of symptom alerts to identify at
risk populations, inform preventative care strategies and drive
efficiencies in care
• Example: Severe nausea/vomiting in neoadjuvant breast cancer
patients
- Opportunity to inform where proactive/preventative care strategies
will be most impactful in alleviating suffering
- Thus reducing avoidable ED visits
- Improving compliance with treatment while also improving
patient’s satisfaction with care

6. A breakthrough cancer care
management platform.
Get In touch today.
2021 Carevive Systems, Inc. All rights reserved.
Confidential & Proprietary information. Do not distribute.
Request a Demo
Debra Wujcik, PhD, RN, FAAN
Debbie@carevive.com